NASDAQ: INO
Inovio Pharmaceuticals Inc Stock Ownership - Who owns Inovio Pharmaceuticals?

Insider buying vs selling

Have Inovio Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Michael John SumnerChief Medical Officer2025-05-15680$1.95
$1.33kSell
Laurent HumeauChief Scientific Officer2025-05-151,708$1.95
$3.33kSell
Peter KiesCFO2025-05-152,566$1.95
$5.00kSell
Jacqueline Elizabeth SheaChief Executive Officer2025-05-157,717$1.95
$15.05kSell
Jacqueline Elizabeth SheaChief Executive Officer2025-05-102,392$1.80
$4.31kSell
Laurent HumeauChief Scientific Officer2025-02-261,584$1.98
$3.14kSell
Jacqueline Elizabeth SheaChief Executive Officer2025-02-262,493$1.98
$4.94kSell
Peter KiesCFO2025-02-262,960$1.98
$5.86kSell
Laurent HumeauChief Scientific Officer2025-02-262,059$1.98
$4.08kSell
Peter KiesCFO2025-02-262,362$1.98
$4.68kSell

1 of 2

INO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when INO insiders and whales buy or sell their stock.

INO Shareholders

What type of owners hold Inovio Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Austin W. Greenhouse David M. Marxe56.31%20,650,987$40.27MInsider
Tee Khiang Ng13.36%4,899,931$9.55MInsider
Deep Track Capital LP8.51%3,119,162$6.08MInstitution
Jong Joseph Kim6.40%2,346,000$4.57MInsider
Blackrock Inc6.32%2,318,480$4.52MInstitution
Vanguard Group Inc5.53%2,028,960$3.96MInstitution
Bank Of America Corp3.56%1,304,987$2.54MInstitution
Geode Capital Management LLC2.31%846,803$1.65MInstitution
Beng Lee Gan2.24%823,045$1.60MInsider
Kevin Rassas1.98%726,088$1.42MInsider

1 of 3

INO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
INO30.31%69.69%Net SellingNet Selling
PYXS34.15%37.69%Net Buying
EPIX36.73%11.07%Net Selling
TELO12.36%16.99%Net Selling
VERU29.87%33.57%Net BuyingNet Buying

Inovio Pharmaceuticals Stock Ownership FAQ

Who owns Inovio Pharmaceuticals?

Inovio Pharmaceuticals (NASDAQ: INO) is owned by 36.80% institutional shareholders, 84.63% Inovio Pharmaceuticals insiders, and 0.00% retail investors. Austin W. Greenhouse David M. Marxe is the largest individual Inovio Pharmaceuticals shareholder, owning 20.65M shares representing 56.31% of the company. Austin W. Greenhouse David M. Marxe's Inovio Pharmaceuticals shares are currently valued at $42.33M.

If you're new to stock investing, here's how to buy Inovio Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.